Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2025-03-21

FDA Approved: AIMOVIG — Supplemental Application (Amgen Inc)

View source ↗

Summary

FDA approved a supplemental application for Aimovig (erenumab-aooe) submitted by Amgen. The approval updates the product labeling per the supplemental submissio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AIMOVIG (ERENUMAB-AOOE)

Snippet

SUPPL AP for AIMOVIG (ERENUMAB-AOOE)